A treatment for breast cancer which is more effective than existing medicines could be a step closer thanks to the "promising" findings of a new study.
READ MORE: Cancer rates soar by 14 per cent in a decade
A compound - called eCF506 - targets a molecule called Src tyrosine kinase that is required for breast cancer cells to grow and spread.
Drugs which target the same molecule are already being tested in clinical trials but researchers claim eCF506 is more selective and does not affect other molecules in the cell.
The team behind the research said this may mean it will be more effective and have fewer side effects than the other drugs in development.
They said further studies are needed but the early findings "are very promising".
READ MORE: New service aims to heal the psychological scars of breast cancer
The study identified the compound through a pioneering approach using imaging techniques to directly visualise the effects of candidate drugs on cells.
Professor Neil Carragher, head of the Edinburgh cancer discovery unit at Edinburgh University who led the study with Dr Asier Unciti-Broceta, said: "This candidate drug will need to undergo further preclinical testing before it can be taken forward into clinical trials, but these early findings are very promising.
"The result provides further support for our new drug discovery approach, which aims to deliver more effective medicines at reduced costs for patients and healthcare providers."
Dr Unciti-Broceta said: "eCF506 is the first drug candidate of a second generation of Src inhibitors that will not only help to understand the complexity of some cancers but also the development of safer combination therapies."
The study, published in the Journal of Medicinal Chemistry, was funded by the Medical Research Council, Wellcome Trust and the commercialisation catalyst Sunergos Innovations.
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules hereComments are closed on this article